Published in Br J Cancer on December 01, 1992
Polymerase chain reaction allelotyping of human ovarian cancer. Br J Cancer (1994) 1.21
Transcriptional map of 170-kb region at chromosome 11p15.5: identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples. Proc Natl Acad Sci U S A (1998) 1.17
The genetic analysis of ovarian cancer. Br J Cancer (1995) 1.16
The long and short of chromosome 11 in breast cancer. Am J Pathol (1998) 0.96
Monoallelic expression of the insulin-like growth factor-2 gene in ovarian cancer. Am J Pathol (1996) 0.89
Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours. Br J Cancer (1995) 0.88
Ovarian cancer has frequent loss of heterozygosity at chromosome 12p12.3-13.1 (region of TEL and Kip1 loci) and chromosome 12q23-ter: evidence for two new tumour-suppressor genes. Br J Cancer (1997) 0.87
Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer. PLoS One (2009) 0.86
Contributions of integrin-linked kinase to breast cancer metastasis and tumourigenesis. J Cell Mol Med (2008) 0.81
Cloning, expression and localization of human BM88 shows that it maps to chromosome 11p15.5, a region implicated in Beckwith-Wiedemann syndrome and tumorigenesis. Biochem J (2001) 0.80
Characterisation of seven human ovarian tumour cell lines. Br J Cancer (1996) 0.77
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (1989) 31.55
Polymorphic DNA region adjacent to the 5' end of the human insulin gene. Proc Natl Acad Sci U S A (1981) 12.86
Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature (1990) 5.13
Tumor suppressor genes. Cell (1991) 3.36
Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell (1991) 3.19
An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell (1990) 3.02
Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism. Nature (1985) 2.96
Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. Am J Hum Genet (1989) 2.56
A locus on chromosome 11p with multiple restriction site polymorphisms. Am J Hum Genet (1984) 2.48
Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues. Nature (1985) 2.29
Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev (1991) 2.20
Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia. Science (1987) 2.17
Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping. Nature (1987) 2.14
A systematic approach for detecting high-frequency restriction fragment length polymorphisms using large genomic probes. Am J Hum Genet (1985) 2.12
Loss of genes on the short arm of chromosome 11 in bladder cancer. Nature (1985) 1.91
Allelotype of human ovarian cancer. Cancer Res (1991) 1.79
WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour. Nature (1991) 1.75
Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung. Proc Natl Acad Sci U S A (1989) 1.73
K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary. Am J Pathol (1991) 1.68
Allele loss from chromosome 17 in ovarian cancer. Oncogene (1990) 1.60
DNA sequence and regional assignment of the human follicle-stimulating hormone beta-subunit gene to the short arm of human chromosome 11. DNA (1987) 1.56
Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms' tumor gene. Cell (1990) 1.52
Localization of the polymorphic human calcitonin gene on chromosome 11. Hum Genet (1984) 1.46
Frequent allelic losses and mutations of the p53 gene in human ovarian cancer. Cancer Res (1991) 1.43
Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas. Cancer Res (1990) 1.42
Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells. Mol Cell Biol (1989) 1.36
Distinction of low grade from high grade human ovarian carcinomas on the basis of losses of heterozygosity on chromosomes 3, 6, and 11 and HER-2/neu gene amplification. Cancer Res (1991) 1.27
Transforming genes in human tumors. J Cell Biochem (1982) 1.22
Allele losses on chromosome 17 in human epithelial ovarian carcinoma. Oncogene (1990) 1.19
Tumor-specific loss of 11p15.5 alleles in del11p13 Wilms tumor and in familial adrenocortical carcinoma. Proc Natl Acad Sci U S A (1989) 1.14
ras oncogene activation in human ovarian carcinoma. Oncogene (1988) 1.13
Loss of heterozygosity on chromosomal segments 3p, 6q and 11p in human ovarian carcinomas. Oncogene (1990) 1.11
Loss of 3p or 11p alleles is associated with testicular cancer tumors. Genomics (1989) 1.01
An RFLP associated with the human catalase gene. Nucleic Acids Res (1985) 0.99
Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level. Br J Cancer (1988) 0.97
Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11. Oncogene (1990) 0.97
Differences in patterns of allelic loss between two common types of adult cancer, breast and colon carcinoma, and Wilms' tumor of childhood. Int J Cancer (1991) 0.92
Allele loss at the retinoblastoma locus in human ovarian cancer. J Natl Cancer Inst (1991) 0.90
A unique pattern of proto-oncogene abnormalities in ovarian adenocarcinomas. Cancer (1988) 0.86
c-myc overexpression is a tumor-specific phenomenon in a subset of human colorectal carcinomas. J Cancer Res Clin Oncol (1990) 0.86
BamHI RFLP at the insulin-like growth factor II (IGF2) locus on chromosome 11. Nucleic Acids Res (1987) 0.85
Amplification of c-ras-Ki oncogene in human ovarian tumours. Int J Cancer (1989) 0.84
Frequent occurrence of Ha-rasl allelic deletion in human ovarian adenocarcinomas. Tumori (1991) 0.81
Allelic loss on the short arm of chromosome 11 in non-small-cell lung cancer. Int J Cancer (1991) 0.81
High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol (1999) 2.80
Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. J Pathol (2000) 2.56
Lithium carbonate in amyotrophic lateral sclerosis: lack of efficacy in a dose-finding trial. Neurology (2010) 2.14
Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol (2001) 2.13
Overexpression of folate binding protein in ovarian cancers. Int J Cancer (1997) 2.13
Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors. Br J Cancer (2001) 1.68
Pharmacokinetic and pharmacodynamic effects of high-dose continuous intravenous verapamil infusion: clinical experience in the intensive care unit. Crit Care Med (1999) 1.50
Diagnosis of thoracic outlet syndrome. Relative value of electrophysiological studies. Acta Neurol Scand (1994) 1.47
Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer. Int J Cancer (1998) 1.36
High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene (1992) 1.30
Three discrete regions of deletion at 3p in head and neck cancers. Cancer Res (1993) 1.29
A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia. Neurology (1999) 1.26
Overexpression of CDC25A and CDC25B in head and neck cancers. Cancer Res (1997) 1.25
Human herpesvirus 6: a survey of presence and variant distribution in normal peripheral lymphocytes and lymphoproliferative disorders. J Infect Dis (1994) 1.24
Characterization of MSH2 and MLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer. Genes Chromosomes Cancer (1997) 1.20
Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. J Clin Oncol (1995) 1.19
Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis. Gut (1999) 1.19
Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol (1998) 1.15
Human herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS. J Infect Dis (1996) 1.11
Accumulation of DNA strand breaks in cells exposed to methotrexate or N10-propargyl-5,8-dideazafolic acid. Cancer Res (1988) 1.10
Ultraviolet-induced p53 mutations in atypical fibroxanthoma. Am J Pathol (1994) 1.08
Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood (1995) 1.07
Pathogenetic and histogenetic features of HIV-associated Hodgkin's disease. Eur J Cancer (2001) 1.05
Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD. Neurology (2002) 1.04
Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood (1997) 1.04
Characterization of MLH1 and MSH2 alternative splicing and its relevance to molecular testing of colorectal cancer susceptibility. Hum Genet (1998) 1.03
Provocative tests in different stages of carpal tunnel syndrome. Clin Neurol Neurosurg (2001) 1.03
Tumor suppressor genes and related molecules in leiomyosarcoma. Am J Pathol (1996) 1.03
High-mobility-group (HMG) proteins and histone H1 subtypes expression in normal and tumor tissues of mouse. Eur J Biochem (1993) 1.03
The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res (2002) 1.02
Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease. Blood (1995) 1.01
CT and MRI of Wernicke's encephalopathy. Radiol Med (2011) 1.01
Prevalence and characteristics of peripheral neuropathy in hepatitis C virus population. J Neurol Neurosurg Psychiatry (2006) 0.99
p53 over-expression is an early event in the development of human squamous-cell carcinoma of the larynx: genetic and prognostic implications. Int J Cancer (1992) 0.99
Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas. Br J Cancer (1997) 0.99
Antimicrobial activity of aqueous extracts and of berberine isolated from Berberis heterophylla. Fitoterapia (2003) 0.98
MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF) Ann Oncol (2000) 0.98
Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis. Cancer Res (1995) 0.98
Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjögren's syndrome. Arthritis Rheum (1997) 0.97
Wernicke encephalopathy after gastrointestinal surgery for cancer: causes of diagnostic failure or delay. Int J Neurosci (2011) 0.97
Simian-virus-40 footprints in human lymphoproliferative disorders of HIV- and HIV+ patients. Int J Cancer (1998) 0.97
Storage levels of DDT metabolites in mouse tissues following long term exposure to technical DDT. Tumori (1972) 0.97
Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature. J Neurol Neurosurg Psychiatry (2010) 0.96
An electromyographic evaluation of motor complications in thoracic herpes zoster. Electromyogr Clin Neurophysiol (1994) 0.96
MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer. Int J Cancer (1998) 0.95
Molecular aberrations of the G1-S checkpoint in myxoid and round cell liposarcoma. Am J Pathol (1997) 0.94
MDM2 overexpression does not account for stabilization of wild-type p53 protein in non-Hodgkin's lymphomas. Blood (1995) 0.94
Hepatitis C virus-related hepatocellular carcinoma and B-cell lymphoma patients show a different profile of major histocompatibility complex class II alleles. Hum Immunol (2004) 0.93
Microsatellite instability in squamous cell carcinomas of the head and neck related to field cancerization phenomena. Br J Cancer (1998) 0.93
Pleiotropic-resistant phenotype is a multifactorial phenomenon in human colon carcinoma cell lines. Br J Cancer (1991) 0.93
Vibration-induced multifocal neuropathy in forestry workers: electrophysiological findings in relation to vibration exposure and finger circulation. Int Arch Occup Environ Health (2000) 0.93
Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process. Int J Cancer (2000) 0.92
Chromosome 13q deletion mapping in head and neck squamous cell carcinomas: identification of two distinct regions of preferential loss. Cancer Res (1996) 0.92
Structure-activity relationship of verapamil analogs and reversal of multidrug resistance. Biochem Pharmacol (1995) 0.92
Role of folate receptor and reduced folate carrier in the transport of 5-methyltetrahydrofolic acid in human ovarian carcinoma cells. Int J Cancer (1998) 0.91
Polymorphism in the major core protein (p30) of murine leukemia viruses as identified by mouse antisera. Virology (1978) 0.91
B-cell clonality and infection with Helicobacter pylori: implications for development of gastric lymphoma. Gut (1996) 0.91
BRCA1 and BRCA2 genes: role in hereditary breast and ovarian cancer in Italy. Int J Cancer (1999) 0.91
Low incidence of BRCA1 mutations among Italian families with breast and ovarian cancer. Int J Cancer (1998) 0.91
Diagnostic specificity of sensory and motor nerve conduction variables in early detection of carpal tunnel syndrome. J Neurol (1989) 0.90
Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma. J Pathol (1997) 0.90
[Bilateral hydrothorax with hydromediastinum after cannulation of the left internal jugular vein]. Minerva Ginecol (1989) 0.89
N-myc activation by proviral insertion in MCF 247-induced murine T-cell lymphomas. Oncogene (1989) 0.89
Expression of glutathione-S-transferase-pi in human tumours. Eur J Cancer (1992) 0.89
Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression. J Clin Oncol (1993) 0.89
A self-administered questionnaire of ulnar neuropathy at the elbow. Neurol Sci (2006) 0.88
All-trans, 13-cis and 9-cis retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: implications for in vivo retinoic acid use. Int J Cancer (1997) 0.88
Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses. Rheumatology (Oxford) (2006) 0.88
Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis. Hepatology (2000) 0.88
Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma. Arthritis Rheum (2000) 0.87
Performance of cytology and colposcopy in diagnosis of cervical intraepithelial neoplasia (CIN) in HIV-positive and HIV-negative women. Cytopathology (2001) 0.87
Cellular and molecular bases of B-cell clonal expansions. Clin Exp Rheumatol (1996) 0.87
p16/CDKN2 and CDK4 gene mutations in sporadic melanoma development and progression. Int J Cancer (1997) 0.86
Local cytokine expression in the progression toward B cell malignancy in Sjögren's syndrome. J Rheumatol (1995) 0.86
c-myc overexpression is a tumor-specific phenomenon in a subset of human colorectal carcinomas. J Cancer Res Clin Oncol (1990) 0.86
Human non-Hodgkin's lymphomas overexpress a wild-type form of p53 which is a functional transcriptional activator of the cyclin-dependent kinase inhibitor p21. Blood (1997) 0.86
Systematic pelvic and para-aortic lymphadenectomy in advanced ovarian cancer patients with no residual intraperitoneal disease. Int J Gynecol Cancer (1997) 0.86
Inter-observer reproducibility and responsiveness of a clinical severity scale in surgically treated carpal tunnel syndrome. Acta Neurol Scand (2002) 0.86
Exercise-induced bilateral anterior tibial compartment syndrome without pain. Ital J Neurol Sci (1986) 0.85
Hepatitis C virus, non-Hodgkin's lymphomas and hepatocellular carcinoma. Br J Cancer (1998) 0.85
Multimodal treatment with neoadjuvant intraarterial chemotherapy and radical surgery in patients with stage IIIB-IVA cervical cancer. A preliminary study. Cancer (1995) 0.85
Carpal tunnel syndrome and ulnar neuropathy at the elbow in floor cleaners. Neurophysiol Clin (2006) 0.85
Pharmacogenetics of irinotecan. Curr Med Chem Anticancer Agents (2003) 0.85
Widespread clonal B-cell disorder in Sjögren's syndrome predisposing to Helicobacter pylori-related gastric lymphoma. Gastroenterology (1996) 0.85
Expression of MDR1 and GST-pi in human soft tissue sarcomas: relation to drug resistance and biological aggressiveness. Ann Oncol (1992) 0.85
Effect of highly active antiretroviral therapy (HAART) on pharmacokinetics and pharmacodynamics of doxorubicin in patients with HIV-associated non-Hodgkin's lymphoma. Ann Oncol (2004) 0.85
Ha-ras-1 restriction fragment length polymorphism and susceptibility to colon adenocarcinoma. Br J Cancer (1987) 0.85
Molecular mechanisms possibly affecting WT1 function in human ovarian tumors. Int J Cancer (1994) 0.84